Hepion Pharmaceuticals Stock (NASDAQ: HEPA) stock price, news, charts, stock research, profile.
You can purchase shares of Hepion Pharmaceuticals (NASDAQ:HEPA) through any online brokerage.
Other companies in Hepion Pharmaceuticals’s space includes: NovaBay Pharmaceuticals (AMEX:NBY), Processa Pharma (NASDAQ:PCSA), cbdMD (AMEX:YCBD), Titan Pharma (NASDAQ:TTNP) and 60 Degrees (NASDAQ:SXTP).
Hepion Pharmaceuticals has a consensus price target of $3.50.
The stock price for Hepion Pharmaceuticals (NASDAQ: HEPA) is $0.66 last updated January 3, 2025 at 7:59 PM EST.
There are no upcoming dividends for Hepion Pharmaceuticals.
Hepion Pharmaceuticals’s Q3 earnings are confirmed for Thursday, November 14, 2024.
There is no upcoming split for Hepion Pharmaceuticals.
Hepion Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.